Retractable Technologies Inc (RVP) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.008x

Based on the latest financial reports, Retractable Technologies Inc (RVP) has a cash flow conversion efficiency ratio of -0.008x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-596.54K) by net assets ($74.38 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Retractable Technologies Inc net asset quality index to measure how much of total assets are equity-financed.

Retractable Technologies Inc - Cash Flow Conversion Efficiency Trend (2000–2025)

This chart illustrates how Retractable Technologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Retractable Technologies Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Retractable Technologies Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Retractable Technologies Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Crunchfish AB
ST:CFISH
-0.074x
Muar Ban Lee Group Bhd
KLSE:5152
0.017x
Wemade Max Co. Ltd
KQ:101730
-0.016x
RHYTHM Biosciences Ltd
AU:RHY
-1.037x
Chonbang
KO:000950
-0.001x
Agat Ejendomme A/S
CO:AGAT
0.005x
Holista Colltech Ltd
AU:HCT
-0.382x
Medicenna Therapeutics Corp
TO:MDNA
-0.799x

Annual Cash Flow Conversion Efficiency for Retractable Technologies Inc (2000–2025)

The table below shows the annual cash flow conversion efficiency of Retractable Technologies Inc from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Retractable Technologies Inc worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $74.38 Million $-7.06 Million -0.095x +28.36%
2024-12-31 $87.17 Million $-11.56 Million -0.133x -575.76%
2023-12-31 $99.29 Million $2.77 Million 0.028x -82.29%
2022-12-31 $106.54 Million $16.77 Million 0.157x -52.40%
2021-12-31 $99.17 Million $32.79 Million 0.331x -13.17%
2020-12-31 $49.88 Million $19.00 Million 0.381x +395.32%
2019-12-31 $28.54 Million $2.19 Million 0.077x +264.74%
2018-12-31 $25.61 Million $-1.20 Million -0.047x +56.60%
2017-12-31 $27.17 Million $-2.92 Million -0.108x -280.31%
2016-12-31 $28.11 Million $-794.91K -0.028x +73.02%
2015-12-31 $31.03 Million $-3.25 Million -0.105x +27.30%
2014-12-31 $26.83 Million $-3.87 Million -0.144x -242.03%
2013-12-31 $28.90 Million $2.93 Million 0.102x +2190.54%
2012-12-31 $35.73 Million $158.34K 0.004x -96.89%
2011-12-31 $38.65 Million $5.51 Million 0.143x -36.44%
2010-12-31 $38.90 Million $8.73 Million 0.224x +165.54%
2009-12-31 $35.92 Million $-12.30 Million -0.342x -143.99%
2008-12-31 $42.21 Million $-5.92 Million -0.140x -72.27%
2007-12-31 $51.76 Million $-4.22 Million -0.081x -45.03%
2006-12-31 $59.71 Million $-3.35 Million -0.056x -58.93%
2005-12-31 $63.24 Million $-2.23 Million -0.035x -103.98%
2004-12-31 $63.66 Million $56.48 Million 0.887x +66.62%
2003-12-31 $15.13 Million $8.06 Million 0.532x +356.54%
2002-12-31 $7.44 Million $-1.54 Million -0.208x +99.08%
2001-12-31 $162.62K $-3.67 Million -22.585x -1909.72%
2000-12-31 $7.37 Million $-8.28 Million -1.124x --

About Retractable Technologies Inc

NYSE MKT:RVP USA Medical Instruments & Supplies
Market Cap
$21.26 Million
Market Cap Rank
#24973 Global
#5243 in USA
Share Price
$0.71
Change (1 day)
+5.01%
52-Week Range
$0.62 - $1.06
All Time High
$21.50
About

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allerg… Read more